Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non-interventional, Multi-cohort, Multi-center, Prospective Real-world Study of Treatment Pattern and Clinical Outcomes in Patients With HER2-overexpressed Advanced Solid Tumors After Progression of First-line Standard Therapy

NCT05649163 is registered in ClinicalTrials.gov with Shen Lin as lead sponsor.

NCT NCT05649163
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05649163 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non-interventional, Multi-cohort, Multi-center, Prospective Real-world Study of Treatment Pattern and Clinical Outcomes in Patients With HER2-overexpressed Advanced Solid Tumors After Progression of First-line Standard Therapy
Lead sponsor
Shen Lin
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2023
Completion date
May 31, 2025
Enrollment
306 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced gastric cancer, advanced gastroesophageal junction adenocarcinoma, advanced solid tumor, her2